Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension
Sponsor: The Third Xiangya Hospital of Central South University
A EARLY_PHASE1 clinical study on Pulmonary Arterial Hypertension, this trial is ongoing. The trial is conducted by The Third Xiangya Hospital of Central South University and has accumulated 6 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status EARLY_PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status Phase 0
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Third Xiangya Hospital of Central South University
- Xiangya Hospital of Central South University
For direct contact, visit the study record on ClinicalTrials.gov .